Pathway Genomics(美國(guó))

Pathway Genomics

美國(guó)PathwayGenomicswww.pathway.comPathwayGenomics擁有并經(jīng)營(yíng)一所現(xiàn)場(chǎng)基因檢測(cè)實(shí)驗(yàn)室，該實(shí)驗(yàn)室已通過(guò)美國(guó)病理學(xué)家學(xué)會(huì)(CAP)的認(rèn)證，該認(rèn)證符合美國(guó)衛(wèi)生及人民服務(wù)部的1988年臨床實(shí)驗(yàn)室改進(jìn)法案修正案(CLIA)，并持有加州頒發(fā)的許可證。該公司僅采用一份唾液樣本，整合了量身定制的、經(jīng)過(guò)科學(xué)驗(yàn)證的技術(shù)來(lái)生成個(gè)性化的報(bào)告，該報(bào)告可回答多種醫(yī)學(xué)問(wèn)題，包括個(gè)體是否 攜帶某種隱性基因、食物代謝與運(yùn)動(dòng)反應(yīng)、處方藥物反應(yīng)以及患某些疾病的傾向，如心臟病、2型糖尿病和癌癥。PathwayGenomicsownsandoperatesanon-sitegenetictestinglaboratorythatisaccreditedbytheCollegeofAmericanPathologists(CAP),accreditedinaccordancewiththeU.S.HealthandHumanServices’ClinicalLaboratoryImprovementAmendments(CLIA)of1988,andlicensedbythestateofCalifornia.Usingonlyasalivasample,thecompanyincorporatescustomizedandscientificallyvalidatedtechnologiestogeneratepersonalizedreports,whichaddressavarietyofmedicalissues,includinganindividual’scarrierstatusforrecessivegeneticconditions,foodmetabolismandexerciseresponse,prescriptiondrugresponse,andpropensitytodevelopcertaindiseasessuchasheartdisease,type